2025-03-11 23:47:13
Latest Post
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Hexaware Inaugurates Global Business Headquarters in Jersey City
HCLTech among Ethisphere's 2025 World's Most Ethical Companies®
Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
Stock Report
Torrent Pharmaceuticals Ltd Q4FY2022 consolidated loss at Rs. 118 crores
Posted On : 2022-05-26 00:22:04( TIMEZONE : IST )
Torrent Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 2187 crores during the period ended March 31, 2022 as compared to Rs. 2156 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -118 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 249 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -6.98 for the period ended March 31, 2022 as compared to Rs. 14.75 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 2187 crs | ₹2156 crs |  1.44% |
| Net Profit | ₹-118 crs | ₹249 crs |  -147.39% |
| EPS | ₹-6.98 | ₹14.75 | -147.32% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 2187 crores during the period ended March 31, 2022 as compared to Rs.1976 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-118 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.324 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-6.98 for the period ended March 31, 2022 as compared to Rs.19.16 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 2187 crs | ₹1976 crs | 10.68% |
| Net Profit | ₹-118 crs | ₹324 crs | -136.42% |
| EPS | ₹-6.98 | ₹19.16 | -136.43% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.8705 crores during the Financial Year ended March 31, 2022 as compared to Rs.8062 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.777 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.1252 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.45.93 for the Financial Year ended March 31, 2022 as compared to Rs.73.98 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹8705 crs | ₹8062 crs | 7.98% |
| Net Profit | ₹777 crs | ₹1252 crs | -37.94% |
| EPS | ₹45.93 | ₹73.98 | -37.92% |
Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 2634.55 as compared to the previous close of Rs. 2592.50. The total number of shares traded during the day was 3457 in over 818 trades.
The stock hit an intraday high of Rs. 2646.65 and intraday low of 2591.80. The net turnover during the day was Rs. 9071512.00.
